Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

generic drugs

  1. H

    Beyond Generics: How Policy and Investment are Positioning India as a Drug Discovery Hub

    India Pharma Poised to Lead Global Biologics Boom as Government Unveils Mega Initiatives New Delhi, Apr 13 India is strategically positioned to assume a leading role in the rapidly evolving global pharmaceutical landscape. With the industry shifting focus towards biologics, biosimilars, and...
    • Himanshu
    • Thread
    • biologics biopharma shakti biosimilars drug discovery generic drugs government policy high-tech medicine indian pharmaceuticals pharmaceutical industry regulatory reform
    • Replies: 0
    • Forum: Business
  2. H

    Alembic Pharmaceuticals Receives USFDA Approval for Paroxetine Tablet

    Alembic Pharmaceuticals Secures USFDA Approval for Generic Paroxetine Extended-Release Tablets Approval Strengthens Alembic’s US Generics Portfolio New Delhi, March 30: Alembic Pharmaceuticals Ltd on Monday announced that it has received final approval from the United States Food and Drug...
    • Himanshu
    • Thread
    • alembic pharmaceuticals extended-release tablets generic drugs major depressive disorder mental health panic disorder paroxetine premenstrual dysphoric disorder social anxiety disorder supplemental abbreviated new drug application (sanda) usfda
    • Replies: 0
    • Forum: Business
  3. H

    India’s Generic Semaglutide Market Faces Branding Dispute

    Dr. Reddy’s to Rename Semaglutide Drug Following Court Concerns Brand Name Change Underway New Delhi – Dr. Reddy’s Laboratories informed the Delhi High Court on Friday that it intends to change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’. This decision follows a judge’s...
    • Himanshu
    • Thread
    • brand name change diabetes dr. reddy's laboratories drug approval generic drugs glp-1 receptor agonist india legal dispute novo nordisk olymra olymviq ozempic pharmaceuticals semaglutide type 2 diabetes
    • Replies: 0
    • Forum: Business
  4. K

    Aurobindo Pharma Shares Rise 2% After USFDA Final Approval for Everolimus Tablets

    Shares of Aurobindo Pharma Ltd. gained as much as 2% on Thursday, February 26, after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration for Everolimus Tablets.The approval allows Eugia Unit I to...
    • Karthik
    • Thread
    • anda approval aurobindo pharma eugia pharma specialities european revenue growth everolimus tablets generic drugs iqvia market data kidney transplant liver transplant oncology drugs organ transplantation pharmaceutical manufacturing pharmaceutical sales research and development us food and drug administration
    • Replies: 0
    • Forum: Stocks
Back
Top